Canadian HealthTech / Life Sciences Investors

Early-stage VC investing in Seed to pre-Series A technology startups, with a sector focus on software, SaaS, cloud services, marketplaces, mobile, big data/analytics, blockchain, fintech, and healthte

Canada's Global Life Sciences Venture, sourcing promising therapeutics research from academic and biotech partners to create new companies of scale and train the next generation of life sciences leade

Focuses on emerging growth companies primarily in financial services, technology, and resource sectors, providing private equity, private debt, and venture capital.

Government of Alberta agency promoting knowledge-based industries and VC in Alberta. Committed $415M to 39 VC funds.

Early-stage biotechnology venture capital focused on the Quebec life sciences ecosystem.

Invests in small and medium-sized Canadian companies in the business and healthcare services and telecom industries.

North American private equity firm focused on selectively acquiring significant interests in high-quality businesses with meaningful growth potential, primarily in services sub-sectors.

Altitude Angels brings together high-net-worth individuals who support high-potential technology founders by providing capital, mentorship, and network access. The group curates early-stage investment

Early-stage life science venture capital fund and major supporter of Quebec's academic innovation, focusing on pre-seed and seed investments to create startups around groundbreaking technologies.

Early-stage impact venture fund focused on transformational technology in Climate and Health solutions.

Capital catalyst for precision medicine and next-generation medical devices at point of value acceleration.

Toronto-based $35MM venture capital fund founded in 2022 investing in early-stage startups across AI, fintech, SaaS, healthcare, and cleantech across North America and internationally.

Focus on technology companies with validated product-market fit ready to accelerate growth. Staged strategy with discovery checks, building conviction by tracking execution.

BDC's debt financing arm providing loans to Canadian businesses across all stages. Over $9.7B in annual loan acceptances across 123+ business centres serving 60,000+ clients. Products include tech com

A $100M BDC fund helping Canadian entrepreneurs get ideas off the ground. Sector-agnostic software focus with cheque sizes of $100K-$1M. Pan-Canadian with particular focus on underserved regions.

A $100M innovative equity investment lab providing capital, training and support for 100+ ambitious women-led businesses committed to delivering measurable positive social impact tied to UN SDGs.

The $300M direct investment component of BDC's Thrive Platform, addressing the equity gap faced by women-led companies. Partners with women entrepreneurs building Canadian technology companies.

A $200M fund — one of the world's largest dedicated to investing in women-led tech companies. Made 38 investments with 8 successful exits. Predecessor to the Thrive Platform.

Leading Canadian mid-market private equity firm with 5 funds raised and 36 deals recorded.

Private investment management company (family office) with a broad portfolio spanning venture capital and private equity, focused primarily in Alberta and Ontario.

BMO's technology and innovation banking group launched in 2019 providing venture debt and growth financing to Canadian tech companies. Expanded aggressively post-SVB to capture market share.

Pre-seed/seed-stage venture fund launched in close partnership with Centech, entirely dedicated to investing in Centech and Quebec's most promising deeptech startups.

Company creation studio that builds, buys and makes seed-stage investments in disruptive consumer products.

Early-stage venture capital firm focused on Atlantic Canada, investing from seed through Series C.

Companies advancing healthy aging, brain health, and dementia care.

The largest network of early stage investors in Ottawa, Gatineau, and Kanata. A leading Canadian angel group focused on lifting the region's entrepreneurial potential and facilitating access to qualit

Canada's second-largest pension fund and one of the world's largest institutional investors. Active direct investor and LP in the Canadian VC ecosystem.

Strategic advice, cash management, and flexible capital solutions to innovation companies. Financing from $1M to $100M+.

Leading Canadian mid-market PE firm investing through buyouts, growth and acquisition financings since 2002.

Venture capital firm investing in high-quality emerging life sciences companies at the pre-clinical and clinical development stage in Canada and the US.

Founder-friendly PE firm focusing on lower mid-market businesses with a focus on generational transitions and succession planning.

Invest in early-stage B2B enterprise software companies with clear product-market fit and strong Canadian angle.

Venture capital fund investing in innovative Canadian companies in the food & beverage and health & wellness sectors.

Connects Canadian businesses of all sizes and maturities, across all industries, to non-dilutive capital through debt financing against tax credits.

Early-stage digital health venture fund investing in Canada and the US.

Award-winning commercialization venture firm building companies with entrepreneurs to accelerate oncology innovation, partnered with the Ontario Institute for Cancer Research (OICR).

Investment management firm specializing in infrastructure and real estate, a subsidiary of Fengate Corporation operating since 1974.

Invest in innovative private companies developing breakthrough therapies. Join last or second-to-last private financing round.

Early stage, emerging and growth-oriented enterprise software companies. Dedicated Enterprise software focus.

Publicly listed provider of flexible growth and alternative capital, supporting revenue-generating, VC-backed, and founder-owned companies seeking growth capital with minimal dilution.

Quebec's largest labour-sponsored venture capital fund with $20B+ in net assets. Provides venture and development capital to thousands of Quebec businesses from startup to expansion.

Active capital model in AI-powered vertical SaaS. Focus on proven product-market fit and compelling unit economics.

CoFounds & Funds B2B AI-native SaaS companies with values-driven leaders.

Early-stage venture capital firm with 6 funds raised and 79 deals recorded, focused primarily in Ontario.

Early-stage life science opportunities in areas of unmet medical need. Company co-creation investment strategy.

Toronto-based growth capital firm founded in 2008, one of Canada's largest investment firms, investing in enterprise software and internet companies with nearly $3B raised across 5 growth funds.

Leading seed-stage venture capital fund based in Toronto, investing across North America with 7 funds raised and 140 deals recorded.

Canada's seed stage VC partner for exceptional B2B founders. Focus on capital efficiency and global scaling.

A community of angels, super angels, family offices, and venture funds investing in Canadian tech startups from pre-seed to Series A since 2008. Canada's most active early-stage investors with 250+ po

Largest non-bank venture debt lender globally with $10B+ portfolio. Active lender to Canadian tech and life sciences companies. Publicly traded (NYSE: HTGC). Provides venture debt from $5M-$200M+.

Non-bank venture lending company providing venture debt to VC-backed technology, life sciences, healthcare, and sustainability companies. Publicly traded (NASDAQ: HRZN). Active in the North American m

Growth capital investment firm providing private funding and merchant banking services to a wide variety of businesses at different stages of development.

Toronto-based private equity fund manager focused on buyout opportunities in the Canadian and American mid-market.

Nova Scotia's early-stage venture capital organization. Provincial crown corporation building Atlantic Canada's innovation ecosystem.

Grows an innovation ecosystem transforming markets and propelling technology companies toward market leadership.

Focus on software companies and AI driving positive impact on global scale. Three strategies: Discovery, Venture, Growth.

Global deeptech and greentech companies reshaping legacy industries. Bridge between Canada and Asia-Pacific.

Growth-stage AI companies with proven product-market fit in Canada and UK.

Nova Scotia's early-stage venture capital organization (Innovacorp), targeting information technology, clean technology and life sciences.

Quebec provincial government's investment arm fostering economic development. Offers loans, loan guarantees, and equity investments, frequently co-investing alongside private VCs.

JPMorgan's Canadian innovation economy unit expanding aggressively with 5 dedicated tech bankers. Hired Scotiabank's former head of TIB (David Rozin) to lead Canadian expansion, picking up hundreds of

MedTech and Digital Health companies improving patient outcomes and expanding access to care.

Fund igniting precision medicine by supporting early-stage discoveries; innovation arm at the intersection of AI and biomarker analysis for metabolic diseases including cancer and diabetes.

Leading North American healthcare VC building transformative biotechnology and medical device companies.

Bridges a critical gap in early-stage funding, catalyzing later-stage funding for promising technology companies across enterprise software, health tech, clean tech and deep tech.

Canada's only early-stage fund dedicated to sustainable agricultural biotechnology.

National Bank's technology banking group offering venture lending, growth and M&A financing for tech companies for over 20 years. Acquired SVB's ~C$1B Canadian loan portfolio in 2023. Also operates NA

Canadian health technology ventures increasing efficiencies and improving outcomes in healthcare.

One of Canada's most active private markets investors for over two decades. $28B USD in AUM across 10 global offices.

Making private equity investments since 1987 on behalf of OMERS, one of Canada's largest pension plans with over $60.8B in assets; manages over $6.5B globally.

Founded in 1984, one of Canada's oldest private equity firms committed to acquiring and building high-quality businesses in partnership with talented management teams.

Led by experienced operators with strong angel and institutional VC track records; founders-first philosophy with commitment to diversity, co-investing with angel investors and seed funds across Canad

Hands-on pre-seed investor backing Newfoundland and Labrador's most ambitious innovation companies.

Toronto-based middle-market private equity firm with 4 funds and 235 deals recorded, primarily in healthcare, financial, and business services.

Health tech and B2B technology at inflection point between commercialization and scale.

Private equity fund exclusively focused on high-growth opportunities in the healthcare field.

Founded in 1994, Toronto-based private equity firm managing several portfolios with assets of $85M.

Invest at intersection of health care and innovation to accelerate technologies improving patient outcomes and health system sustainability.

Global venture capital company focused on equity financing of innovative biotechnology companies with breakthrough technology platforms.

Canada-Silicon Valley Series A venture fund concentrating on investments just before scaling begins, with 2 funds and 8 deals recorded.

Backer of Canada's most daring innovators and idea generators; RBC's technology growth banking and venture arm.

Innovative private equity fund supporting entrepreneurs and executives fostering innovation in Canada's health and wellness industry.

Focus on most common age-related conditions: brain health, diabetes, cardiovascular, mobility, respiratory, musculoskeletal.

Early-stage VC focused on companies developing creator and developer tools and enterprise software across software, cloud, health tech, crypto, and fintech.

Private venture capital and mutual fund management company with 1 fund and 51 deals recorded.

Scotiabank's tech lending arm with ~C$2B lent to Canadian tech companies including BenchSci, Helcim, GeoComply, and Field Effect. Launched in 2019, expanded post-SVB collapse. Also operates via subsid

Emerging life science companies developing innovative medical treatments based on disruptive technologies.

Building global healthcare leaders from locally disruptive technologies. MedTech, Biotech, AI in Health.

Global investment firm with $620M+ USD in AUM. Partners with visionary founders across technology and healthcare. Fund III closed at $338M CAD.

Founders of Canadian startups leading to a more sustainable, healthy, and equitable world.

Lead seed-stage rounds into B2B software companies. Five-pillar Founder Growth Platform.

Toronto-based early-stage VC fund investing in high-growth technology startups led or co-led by women founders, backing globally competitive companies across enterprise software, digital health, and f

Venture banking division of Stifel providing venture debt ($1M-$50M+), treasury management, and capital raising for seed through IPO-stage tech companies. Over 100 bankers, $10B+ in loan commitments.

Strategic investment arm in AgTech, Digital HealthTech, Connected Consumer, and Enterprise Platforms & IoT.

Canada's largest innovation-focused fund-of-funds investor. Backed by CDPQ, Fondaction, and government programs, with over $2.5B committed to 5 specialized VC fund-of-funds.

Igniting venture growth for greater human impact; 2 funds raised and 49 deals recorded, primarily in Alberta.

Non-bank venture debt and equipment financing provider for growth-stage companies backed by leading venture capital firms. Publicly traded (NASDAQ: TRIN). Active lender in the North American market in

Two themes: AI & Analytics and Disruptive HardTech. Target companies with sustainable technological advantages.

Back mission-driven founders early in new areas. Focus on crypto, deep tech, and enterprise SaaS.

Flexible growth capital solutions (debt, convertible debt, structured equity) to mid-later stage technology companies. $10M-$50M.

Montreal-based PE firm partnering with management teams of mid-market businesses in Quebec and Canada to drive growth.

Venture capital and private equity manager of Golden Opportunities Fund Inc. and First Nations and Métis Fund (FNMF), with 7 funds and 179 deals.

Pioneered venture debt in 1980. $7.8B deployed across 1,400+ companies including Canadian firms. Now investing out of 11th institutional fund. Acquired by P10 in 2022. Flexible, founder-friendly lendi

International technology investment manager. Early Growth Fund, Digital Asset Fund, and North American Seed Fund.